ENG/中
老虎證券
市场
行情
24/7新闻
产品
Cash Boost账户
期权
A股通
港股
固定票息票据
美股
ETF
基金超市
美国国债
新加坡股
期货
Tiger BOSS Debit Card
老虎钱袋子
功能
经纪人
定投
CPF/SRS 投资
专栏
美股碎股
TigerAI
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
机构
Tiger Fund Management
机构服务
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
老虎API平台
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
Direxion Daily Biotech Top 5 Bull 2X ETF
38.36
-0.5386
-1.38%
盤後:
38.53
0.1700
+0.44%
16:10 EDT
成交量:
7,280
成交額:
28.42萬
市值:
287.70萬
市盈率:
- -
高:
39.06
開:
39.06
低:
38.36
收:
38.90
52周最高:
45.88
52周最低:
25.71
股本:
7.50萬
流通股本:
7.50萬
量比:
0.49
換手率:
9.71%
股息:
0.62
股息率:
1.62%
淨資產收益率:
--
總資產收益率:
--
市淨率:
--
市盈率(LYR):
- -
資料載入中...
總覽
公司
新聞
公告
美國食品藥品監督管理局(FDA)批准吉利德治療艾滋病的每日一次複方片劑
路透中文
·
08/28
美國FDA批准吉利德科學Bixlenvo™上市:每日單片方案為病毒學抑制HIV成人患者提供新選擇,涵蓋複雜治療方案人群
美股速递
·
08/28
英國股市——8月27日需關注的因素
路透中文
·
08/27
阿斯利康的哮喘藥物Tezspire在食管炎晚期臨床試驗中達到了所有目標
路透中文
·
08/27
Tezspire®在嗜酸性食管炎III期臨床試驗中展現積極成果,共同主要終點及所有關鍵次要終點全面達標
美股速递
·
08/27
美股開盤|三大指數升跌不一;Meta升逾3%、小鵬汽車升逾3%;生物科技股活躍
美股开盘
·
08/26
羅兵咸永道:上半年中國併購交易量7316宗創歷史新高 預計下半年延續強勁勢頭
智通财经
·
08/25
歐盟委員會擴大吉利德Trodelvy®在轉移性三陰性乳腺癌一線治療中的應用範圍,覆蓋所有PD-L1狀態
美股速递
·
08/24
吉利德科學:歐盟批准Trodelvy聯合Keytruda用於一線PD-L1陽性轉移性三陰性乳腺癌
美股速递
·
08/24
美國聯邦貿易委員會(FTC):安進專利申請收購交易受到反壟斷審查。
智通财经
·
08/21
Piper Sandler上調安進目標價至457美元
格隆汇
·
08/21
美國研究綜述-安進、Analog Devices、莫德納
路透中文
·
08/20
港股早評:三大指數高開逾1.1%,生物科技股、黃金股大漲
中金财经
·
08/20
AI生物科技股Twist Bioscience升逾22%
格隆汇
·
08/20
福泰製藥(VRTX)股票8月19日收盤上漲4.48%:釋放什麼信號?
TradingKey中文
·
08/20
吉利德科學(GILD)股票8月19日盤中上漲3.66%:背後推手曝光
TradingKey中文
·
08/20
安進(AMGN)股票8月19日盤中上漲3.19%:背後推手曝光
TradingKey中文
·
08/20
再生元製藥旗下Pasatru獲歐洲藥品管理局審評,全球申報在即
美股速递
·
08/20
再生元製藥獲FDA批准:Pasatru(Garetosmab-Grts)上市,治療成人進行性骨化性纖維發育不良
美股速递
·
08/20
受利好消息提振,美股生物科技股普漲
智通财经
·
08/19
更多
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/stock/TBXU/news?page=3"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"TBXU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TBXU\",,,,,undefined,":{"symbol":"TBXU","market":"US","secType":"STK","nameCN":"Direxion Daily Biotech Top 5 Bull 2X ETF","latestPrice":38.3601,"timestamp":1789156800000,"preClose":38.8987,"halted":0,"volume":7280,"hourTrading":{"tag":"盘后","latestPrice":38.5301,"preClose":38.3601,"latestTime":"16:10 EDT","volume":6,"amount":230.1604,"timestamp":1789157404900,"change":0.17,"changeRate":0.004432,"amplitude":0},"delay":0,"changeRate":-0.01384622108193835,"floatShares":75001,"shares":75001,"eps":0,"marketStatus":"未開盤","change":-0.5386,"latestTime":"09-11 16:00:00 EDT","open":39.06,"high":39.06,"low":38.3601,"amount":284204,"amplitude":0.017993,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":2,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1789372800000},"marketStatusCode":0,"adr":0,"exchange":"ARCA","adjPreClose":38.8987,"sharesOutstanding":100001,"nav":38.336,"aum":2875239.83,"dividendRate":0.01621,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":38.5301,"preClose":38.3601,"latestTime":"16:10 EDT","volume":6,"amount":230.1604,"timestamp":1789157404900,"change":0.17,"changeRate":0.004432,"amplitude":0},"volumeRatio":0.4910292679310407},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TBXU\",,,,,undefined,":{"symbol":"TBXU","floatShares":75001,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.4910292679310407,"shares":75001,"dividePrice":0.6218,"high":39.06,"amplitude":0.017993,"preClose":38.8987,"low":38.3601,"week52Low":25.71,"pbRate":"--","week52High":45.88,"institutionHeld":0,"latestPrice":38.3601,"eps":0,"divideRate":0.01621,"volume":7280,"delay":0,"ttmEps":0,"open":39.06,"prevYearClose":31.065,"prevWeekClose":44.3833,"prevMonthClose":42.9245,"prevQuarterClose":32.1223,"fiveDayClose":45.76,"twentyDayClose":38.3309,"sixtyDayClose":29.86},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TBXU\",params:#limit:5,,,undefined,":[{"date":"2026-06-23","symbol":"TBXU","amount":0.11101,"announcedDate":"2026-06-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-23","defaultRemindTime":1782221400000,"name":"Direxion Daily Biotech Top 5 Bull 2X ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-30","payableDate":"2026-06-23","currency":"USD","dateTimestamp":1782187200000,"payDate":"2026-06-30"},{"date":"2026-03-24","symbol":"TBXU","amount":0.09893,"announcedDate":"2026-03-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-24","defaultRemindTime":1774359000000,"name":"Direxion Daily Biotech Top 5 Bull 2X ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-31","payableDate":"2026-03-24","currency":"USD","dateTimestamp":1774324800000,"payDate":"2026-03-31"},{"date":"2025-12-23","symbol":"TBXU","amount":0.10111,"announcedDate":"2025-12-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-23","defaultRemindTime":1766500200000,"name":"Direxion Daily Biotech Top 5 Bull 2X ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-31","payableDate":"2025-12-23","currency":"USD","dateTimestamp":1766466000000,"payDate":"2025-12-31"},{"date":"2025-12-10","symbol":"TBXU","amount":0.31143,"announcedDate":"2025-12-09","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-10","defaultRemindTime":1765377000000,"name":"Direxion Daily Biotech Top 5 Bull 2X ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-17","payableDate":"2025-12-10","currency":"USD","dateTimestamp":1765342800000,"payDate":"2025-12-17"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TBXU\",market:\"US\",,,undefined,":[{"executeDate":"2025-12-10","recordDate":"2025-12-10","paymentDate":"2025-12-17","value":0.31143,"currency":"USD"},{"executeDate":"2025-12-23","recordDate":"2025-12-23","paymentDate":"2025-12-31","value":0.10111,"currency":"USD"},{"executeDate":"2026-03-24","recordDate":"2026-03-24","paymentDate":"2026-03-31","value":0.09893,"currency":"USD"},{"executeDate":"2026-06-23","recordDate":"2026-06-23","paymentDate":"2026-06-30","value":0.11101,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TBXU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TBXU\",pageSize:20,pageCount:3,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2662036374","title":"美國食品藥品監督管理局(FDA)批准吉利德治療艾滋病的每日一次複方片劑","url":"https://stock-news.laohu8.com/highlight/detail?id=2662036374","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662036374?lang=zh_tw&edition=fundamental","pubTime":"2026-08-28 05:50","pubTimestamp":1787867453,"startTime":"0","endTime":"0","summary":"美国食品药品监督管理局(FDA)批准吉利德治疗艾滋病的每日一次复方片剂路透8月27日-吉利德科学公司周四表示,美国食品和药物管理局已批准该公司研发的每日一次口服复方药GILD.O,用于治疗HIV病毒载量已降至极低水平的成人患者。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nL4S44O24V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BZ1G4Q59.USD","LU0861579265.USD","LU2112291526.USD","LU0889565916.HKD","LU2324357040.USD","IE00B7SZLL34.SGD","BK4532","BK4583","GILD","BK4568","IE00B3T34201.USD","SG9999015986.USD","BMED","BBH","LU0965509283.SGD","IBBQ","LU0289739699.SGD","TBXU","LU1061106388.HKD","BK4566","MEDI","IE0002270589.USD","LU1674673691.USD","LU1934455277.USD","SG9999015952.SGD","SG9999015945.SGD","LU0114720955.EUR","TMED","BIB","IBB","LU1037948541.HKD","LU0109394709.USD","LU1023059063.AUD","SG9999015978.USD","BK4139","LU1839511570.USD","IE00B19Z3581.USD","LU1066053197.SGD","IE00BKVL7J92.USD","LU0965508806.USD","LU1430594728.SGD","LU1778281490.HKD","BK4585","LU2468319806.SGD","LU1037948897.HKD","LU1934455194.USD","LU1571399168.USD","LU0965509101.SGD","LU0058720904.USD","LU0823416689.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198194055","title":"美國FDA批准吉利德科學Bixlenvo™上市:每日單片方案為病毒學抑制HIV成人患者提供新選擇,涵蓋複雜治療方案人群","url":"https://stock-news.laohu8.com/highlight/detail?id=1198194055","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1198194055?lang=zh_tw&edition=fundamental","pubTime":"2026-08-28 05:49","pubTimestamp":1787867358,"startTime":"0","endTime":"0","summary":"美国食品药品监督管理局正式批准了吉利德科学旗下新药Bixlenvo。这款每日一次的单片制剂,专为病毒学抑制状态的HIV成人感染者设计——即便是那些正在接受复杂治疗方案的病患,也适用这一新选项。此项获批标志着HIV治疗领域又添一枚重要砝码。Bixlenvo以单片复方形式呈现,将给药频率与用药负担同步压缩,患者无需再面对繁琐的多药组合。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0122379950.USD","LU2357627491.SGD","SG9999015978.USD","LU1066051498.USD","LU1934455194.USD","LU1061106388.HKD","IE00BZ1G4Q59.USD","LU1674673428.USD","TMED","SG9999015952.SGD","IBB","LU1023059063.AUD","LU0320765992.SGD","BK4583","BK4588","LU2087621335.USD","BK4585","IBBQ","LU0965509010.AUD","LU1778281490.HKD","LU0965508806.USD","LU1585245621.USD","BK4578","BK4550","IE00B19Z3581.USD","LU0823416689.USD","LU0882574055.USD","LU2089984988.USD","TBXU","LU0289739699.SGD","LU0861579265.USD","LU0965509283.SGD","IE00B7SZLL34.SGD","LU1037948541.HKD","LU1571399168.USD","LU1674673691.USD","SG9999015986.USD","IE0002270589.USD","LU0109394709.USD","LU1430594728.SGD","BK4568","LU0889565916.HKD","LU1934455277.USD","BBH","BMED","LU2112291526.USD","BIB","LU0058720904.USD","LU0859254822.USD","LU1057294990.SGD","IE00B3T34201.USD","MEDI","LU2324357040.USD","LU0114720955.EUR","IE00B19Z3B42.SGD","IE00BKVL7J92.USD","LU0234570918.USD","LU0965509101.SGD","LU1037948897.HKD","IE00BSNM7G36.USD","LU1839511570.USD","LU2468319806.SGD","LU1066053197.SGD","LU1934455863.HKD","BK4532","GILD","SG9999015945.SGD","BK4139","BK4566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662775484","title":"英國股市——8月27日需關注的因素","url":"https://stock-news.laohu8.com/highlight/detail?id=2662775484","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662775484?lang=zh_tw&edition=fundamental","pubTime":"2026-08-27 14:53","pubTimestamp":1787813617,"startTime":"0","endTime":"0","summary":"更新 1-英国股市——8月27日需关注的因素新增新闻报导,更新期货行情路透8月27日-预计周四英国富时100指数.FTSE将低开,期货FFIc1下跌0.4%。*7月汽车产量:行业数据显示,受出口疲软及部分工厂提前进行夏季检修停产影响,英国7月汽车产量 同比下降11.6%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nL4T44O0JK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AMGN","LU1880407132.USD","LU0171276677.USD","PPH.UK","LU0963555726.SGD","LU0969580561.USD","LU0553294199.USD","LU0171293334.USD","BK5105","LU0949170426.SGD","LU1057294990.SGD","LU0868494617.USD","BBH","LU0345780950.USD","LU1267930573.SGD","BK4139","LU1104425308.USD","BIB","GLEN.UK","PBE","BK4585","TBXU","SGXZ57979304.SGD","LU0857590862.USD","LU0889565916.HKD","LU0792757196.USD","PRU.UK","LU1989771016.USD","LU1355424745.HKD","IBB","LU0075056555.USD","LU2089984988.USD","PJP","IBBQ","LU1119994496.HKD","SG9999001176.SGD","LU0122379950.USD","LU1989772923.USD","LU1267930227.SGD","LU0310800379.SGD","AZN.UK","03165","LU2293690082.USD","CRDA.UK","LU0047713382.USD","GAW.UK","HFD.UK","LU0211326755.USD","IE0034235188.USD","LU0345777147.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662639773","title":"阿斯利康的哮喘藥物Tezspire在食管炎晚期臨床試驗中達到了所有目標","url":"https://stock-news.laohu8.com/highlight/detail?id=2662639773","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662639773?lang=zh_tw&edition=fundamental","pubTime":"2026-08-27 14:08","pubTimestamp":1787810905,"startTime":"0","endTime":"0","summary":"阿斯利康的哮喘药物Tezspire在食管炎晚期临床试验中达到了所有目标路透8月27日-阿斯利康(AstraZeneca)AZN.L周四表示,其与安进(Amgen)AMGN.O联合开发的哮喘药物Tezspire,在治疗嗜酸性粒细胞性食管炎(一种食管的慢性炎症性疾病)的晚期临床试验中达到了主要和次要研究目标。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nL4T44O0GC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1923622614.USD","LU0949170426.SGD","LU0171276677.USD","BK5011","BIB","LU0011850046.USD","LU0203345920.USD","LU2237443549.SGD","LU1015430645.USD","LU0882574055.USD","LU1119994496.HKD","AMGN","LU2125909247.SGD","BK4139","LU2089284900.SGD","IBB","LU1273509221.SGD","LU1061106388.HKD","TBXU","PBE","AZN.UK","LU0432979614.USD","03165","LU1323610961.USD","LU2357627491.SGD","LU0889565916.HKD","IE00B2B36J28.USD","BBH","LU0211327993.USD","IE00BFTCPJ56.SGD","LU0211328371.USD","IBBQ","BK4588","BK4599","LU0757432116.USD","LU0390134368.USD","LU1267930813.SGD","LU1989772840.SGD","LU1196032939.SGD","PJP","LU1261432733.SGD","LU0158827948.USD","LU1064927863.SGD","LU1481599808.USD","LU0496365809.HKD","LU0960981461.USD","LU0640478417.SGD","LU0526926950.USD","LU0557290698.USD","LU0823416689.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146489142","title":"Tezspire®在嗜酸性食管炎III期臨床試驗中展現積極成果,共同主要終點及所有關鍵次要終點全面達標","url":"https://stock-news.laohu8.com/highlight/detail?id=1146489142","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1146489142?lang=zh_tw&edition=fundamental","pubTime":"2026-08-27 14:00","pubTimestamp":1787810443,"startTime":"0","endTime":"0","summary":"Tezspire在针对嗜酸性食管炎的III期临床试验中取得了令人瞩目的积极结果。该试验不仅成功达到了共同主要终点,而且所有关键次要终点也悉数告捷。Tezspire的优异表现,标志着该领域治疗可能迎来重大变革。共同主要终点的同时达成,以及关键次要终点的全面覆盖,充分验证了Tezspire的疗效一致性和临床获益的广泛性。业内专家指出,Tezspire的这项研究成果,不仅巩固了其在炎症性疾病治疗领域的地位,更可能为后续的监管审批和市场推广奠定坚实基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1983299246.USD","LU0320765992.SGD","LU2242646821.SGD","IE0002141913.USD","LU1061106388.HKD","LU1057294990.SGD","BK4139","PJP","LU0868494617.USD","BBH","LU0889565916.HKD","SG9999001440.SGD","LU2089984988.USD","BK4585","IBB","LU0109394709.USD","LU2468319806.SGD","IE00BFTCPJ56.SGD","IE0009355771.USD","IE00BJT1NW94.SGD","LU1571399168.USD","LU1023059063.AUD","LU2112291526.USD","IE00B4R5TH58.HKD","IE00B2B36J28.USD","BIB","BK4581","IE00BJJMRZ35.SGD","BK4534","BK4566","LU0289739699.SGD","IBBQ","BK4533","BK4599","LU0058720904.USD","LU0122379950.USD","AMGN","LU2242652126.USD","TBXU","PBE","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1106797728","title":"美股開盤|三大指數升跌不一;Meta升逾3%、小鵬汽車升逾3%;生物科技股活躍","url":"https://stock-news.laohu8.com/highlight/detail?id=1106797728","media":"美股开盘","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1106797728?lang=zh_tw&edition=fundamental","pubTime":"2026-08-26 21:30","pubTimestamp":1787751055,"startTime":"0","endTime":"0","summary":"投资者在英伟达财报公布前保持观望,市场情绪较为谨慎。公司拟通过部分赔偿及功能调整降低监管不确定性,股价盘前显著反弹。美国第二季度实际GDP年化季率维持1.5%。美国7月核心PCE同比增长3.3%,通胀黏性仍存。管理层警示激烈竞争对利润率造成压力,股价盘后回落近4%。营收及利润双双下滑,显示美国消费者支出放缓。公司宣称AI可服务的潜在市场规模高达30万亿美元,市场热议其估值合理性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1575","BK4505","BK4551","BK1610","BK4099","LU0593848301.USD","EVS.SI","BK1119","BK1588","XPEG","BK4526","TBXU","BK1587","BK4555","BK1539","XPEV","09868","BIOY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662784028","title":"羅兵咸永道:上半年中國併購交易量7316宗創歷史新高 預計下半年延續強勁勢頭","url":"https://stock-news.laohu8.com/highlight/detail?id=2662784028","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662784028?lang=zh_tw&edition=fundamental","pubTime":"2026-08-25 16:00","pubTimestamp":1787644859,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,普华永道指出,今年上半年,中国并购交易数量达7316宗,同比增加近30%,创下历史新高;交易总额同比增长56%至2416亿美元,为2023年以来最佳半年度表现。普华永道交易服务税务主管合伙人梅梁表示,预期中国并购市场在2026年下半年将延续强劲势头,全年交易总额有望实现同比增长。港交所仅上半年即录得51宗具私募股权背景的IPO,创下同期历史新高,超过半数为高科技企业。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1484962.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["MMID","UYG","PEVC","ACTV","GTPE","IBBQ","XLFI","BK4588","IEFN","PBPH","DFMC","IYH","TMED","PSP","TBXU","CANC","BK4585","AAUM","PRVT","RFG","VXF","FFSM","MNA","RSPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1186632498","title":"歐盟委員會擴大吉利德Trodelvy®在轉移性三陰性乳腺癌一線治療中的應用範圍,覆蓋所有PD-L1狀態","url":"https://stock-news.laohu8.com/highlight/detail?id=1186632498","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1186632498?lang=zh_tw&edition=fundamental","pubTime":"2026-08-24 18:32","pubTimestamp":1787567559,"startTime":"0","endTime":"0","summary":"欧盟委员会近日作出重要决定,将吉利德科学(Gilead Sciences)旗下重磅药物Trodelvy®的适用范围进一步拓宽。此次调整聚焦于转移性三阴性乳腺癌的一线治疗领域,且不再受限于患者的PD-L1表达状态。这一举措意味着,无论生物标志物检测结果如何,符合条件的患者均有望从该疗法中获益。此举不仅为临床医生提供了更为灵活的用药选择,也标志着Trodelvy®在肿瘤治疗版图中的地位得到显著提升。吉利德科学方面对此表示积极回应,认为该批准将助力满足更多患者未被满足的医疗需求。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BZ1G4Q59.USD","LU1066053197.SGD","TMED","BK4566","LU2089984988.USD","LU2324357040.USD","BK4578","BBH","LU0122379950.USD","SG9999015952.SGD","TBXU","LU1057294990.SGD","BMED","BK4588","LU2468319806.SGD","BK4568","LU1934455863.HKD","LU0965509010.AUD","IBB","IE00B7SZLL34.SGD","LU1839511570.USD","BK4550","LU0320765992.SGD","IE00BSNM7G36.USD","BK4139","LU0114720955.EUR","LU0109394709.USD","LU0859254822.USD","LU1585245621.USD","LU1674673691.USD","LU2087621335.USD","LU2112291526.USD","IE00B19Z3581.USD","SG9999015978.USD","IE00BKVL7J92.USD","LU1037948541.HKD","LU0823416689.USD","LU0234570918.USD","LU0889565916.HKD","LU1934455277.USD","LU1934455194.USD","LU0882574055.USD","LU2357627491.SGD","BK4585","LU1061106388.HKD","LU1037948897.HKD","LU0861579265.USD","LU0965508806.USD","LU1571399168.USD","IBBQ","LU0058720904.USD","LU0965509101.SGD","LU0965509283.SGD","BIB","IE00B19Z3B42.SGD","BK4583","LU1674673428.USD","SG9999015986.USD","LU1430594728.SGD","BK4532","LU1023059063.AUD","LU1066051498.USD","LU1778281490.HKD","MEDI","GILD","LU0289739699.SGD","SG9999015945.SGD","IE00B3T34201.USD","IE0002270589.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193380081","title":"吉利德科學:歐盟批准Trodelvy聯合Keytruda用於一線PD-L1陽性轉移性三陰性乳腺癌","url":"https://stock-news.laohu8.com/highlight/detail?id=1193380081","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1193380081?lang=zh_tw&edition=fundamental","pubTime":"2026-08-24 18:32","pubTimestamp":1787567533,"startTime":"0","endTime":"0","summary":"吉利德科学公司宣布,欧盟已正式授予其抗体药物偶联物Trodelvy与默沙东的Keytruda联合用药方案的上市许可。这一批准针对的是既往未经治疗的PD-L1阳性转移性三阴性乳腺癌患者群体。此项授权标志着该联合疗法在欧盟地区的临床可及性迈出关键一步,为这类侵袭性强、治疗选择有限的乳腺癌亚型患者提供了新的一线治疗选项。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2357627491.SGD","IBBQ","LU0889565916.HKD","LU1066053197.SGD","SG9999015978.USD","LU0965509283.SGD","TBXU","IE00B7SZLL34.SGD","LU1037948897.HKD","GILD","IE0002270589.USD","LU0965509101.SGD","LU1066051498.USD","IE00B19Z3B42.SGD","LU2324357040.USD","LU1674673691.USD","BMED","LU0861579265.USD","LU1934455277.USD","LU0965509010.AUD","BK4532","LU1778281490.HKD","LU0320765992.SGD","BK4566","BK4568","LU1430594728.SGD","BK4139","IE00BKVL7J92.USD","IE00BSNM7G36.USD","LU0114720955.EUR","LU0965508806.USD","LU1023059063.AUD","LU2087621335.USD","LU0882574055.USD","LU1585245621.USD","IE00B19Z3581.USD","IE00BZ1G4Q59.USD","BBH","IBB","LU0058720904.USD","BK4583","LU1674673428.USD","LU1934455863.HKD","LU1037948541.HKD","LU1839511570.USD","LU2112291526.USD","SG9999015952.SGD","LU0109394709.USD","LU2089984988.USD","LU0859254822.USD","BK4578","MEDI","LU2468319806.SGD","LU1934455194.USD","IE00B3T34201.USD","BK4550","SG9999015986.USD","TMED","LU0122379950.USD","LU1571399168.USD","BK4585","LU1057294990.SGD","LU0823416689.USD","BK4588","LU0289739699.SGD","LU0234570918.USD","BIB","LU1061106388.HKD","SG9999015945.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661291370","title":"美國聯邦貿易委員會(FTC):安進專利申請收購交易受到反壟斷審查。","url":"https://stock-news.laohu8.com/highlight/detail?id=2661291370","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661291370?lang=zh_tw&edition=fundamental","pubTime":"2026-08-21 23:49","pubTimestamp":1787327356,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BBH","IXP","RSPT","HCA","JHMT","NBDS","KEMQ","TDAQ","TRUC","BUYO","DISC","PJP","PBE","TGRW","AMGN","IEME","NBCC","MSFY","GOOX","LRGG","QQMG","XLCI","ORCZ","IBB","MSFX","EMQQ","GXPC","WEBX","FCOM","ONEQ","FTC","WEBL","MNA","BIB","GXPT","CWC","EVNT","ARB","JHCS","MRGR","TBXU","GGTL","IHF","IBBQ","BWEB","DRUP","PBS","BCTK","MUSQ","PNQI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661250489","title":"Piper Sandler上調安進目標價至457美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2661250489","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661250489?lang=zh_tw&edition=fundamental","pubTime":"2026-08-21 15:20","pubTimestamp":1787296801,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU2468319806.SGD","LU0122379950.USD","IBB","LU1023059063.AUD","IE00BFTCPJ56.SGD","LU0109394709.USD","LU1057294990.SGD","UDN","BK4581","BK4534","IBBQ","IE00B4R5TH58.HKD","BK4566","BK4588","IE00B2B36J28.USD","BIB","LU1571399168.USD","LU0889565916.HKD","LU0320765992.SGD","PBE","LU1061106388.HKD","SG9999001440.SGD","AMGN","LU0058720904.USD","LU2112291526.USD","BK4585","IE0009355771.USD","LU2242652126.USD","LU0289739699.SGD","IE0002141913.USD","TBXU","BK4599","BBH","IE00BJT1NW94.SGD","LU0868494617.USD","LU1983299246.USD","LU2242646821.SGD","BK4533","LU2089984988.USD","PJP","UUP","IE00BJJMRZ35.SGD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660043834","title":"美國研究綜述-安進、Analog Devices、莫德納","url":"https://stock-news.laohu8.com/highlight/detail?id=2660043834","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660043834?lang=zh_tw&edition=fundamental","pubTime":"2026-08-20 15:49","pubTimestamp":1787212153,"startTime":"0","endTime":"0","summary":"美国研究综述-安进、Analog Devices、莫德纳路透8月20日-周四,华尔街证券分析师上调了多家在美国上市公司的评级和目标股价,其中包括安进、模拟设备公司和莫德纳。股票按字母顺序排列。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nL4S44H0HV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CLOU","IE00BJJMRZ35.SGD","LU1235294995.USD","LU1057294990.SGD","LU1670711040.USD","IYH","LU2506952170.USD","IE00BDGV0183.EUR","IGV","LU2298322129.HKD","LU1064131342.USD","MRNY","LU1815336760.USD","LU0058720904.USD","SG9999000418.SGD","IE00BZ9MQY76.HKD","WISE","SG9999001176.SGD","ABBV","LU2517655028.SGD","LU1551013425.SGD","IE000M9KFDE8.USD","SG9999014039.USD","IDNA","LU0068578508.USD","LU0965508806.USD","LU2023250843.SGD","LU2322448791.USD","LU0211327993.USD","BK4599","LU0912757837.SGD","LU2458330243.SGD","LU2237443549.SGD","LU1623119135.USD","FDTX","VHT","LU1169589451.USD","IE00B1BXHZ80.USD","BK4535","LU2242646821.SGD","LU2129689514.USD","IE000F7OJYX1.SGD","BK4550","LU0320765992.SGD","LU1861214812.USD","LU1150488218.USD","SG9999015986.USD","LU2461242641.AUD","LU0081259029.USD","LU0820561818.USD","MRNX","SG9999014021.USD","LU1941712264.USD","LU0256863811.USD","MRVX","LU1839511570.USD","LU1917777945.USD","IE00B3PB1722.GBP","LU1941712348.USD","BUG","LU0158827948.USD","IE0009356076.USD","LU1093756168.USD","LU2552382058.USD","LU0661504455.SGD","LU0985320562.USD","IE0004091025.USD","LU1989763005.USD","LU0256863902.USD","LU0122379950.USD","CRWC","BK4185","GTEK","LU0690374615.EUR","LU1732800096.USD","IE00B2B36J28.USD","LU2552382215.SGD","LU1720051017.SGD","LU2298321311.HKD","SNOU","LU0417517546.SGD","CLOD","BK4501","LU2357305700.SGD","PJP","LU2092937221.SGD","BK4533","LU0130517989.USD","TRUH","LU1291159041.SGD","LU2089985449.USD","SGXZ57979304.SGD","TJX","LU0950375773.USD","LU2487616109.SGD","LU1162221912.USD","LU1267930490.SGD","MEDX","ARTY","LU0127658192.USD","BK4534","SG9999014542.SGD","LU0310799852.SGD","LU0511384066.AUD","BK4528","LU2129689431.USD","LU2023250504.SGD","IE0002270589.USD","LU1823568750.SGD","LU1023059063.AUD","LU0823417737.USD","IE00BVYPNV92.GBP","IE000WAW04H5.SGD","CIBR","BK4558","BIB","LU1989771016.USD","LU1585245621.USD","BMED","LU2360106780.USD","LU0289739343.SGD","LU1037948897.HKD","IE00B5949003.HKD","LU0943347566.SGD","LU0868494617.USD","LU0545039389.USD","BK4505","LU1046421795.USD","LGHT","LU0795875169.SGD","LU1861220033.SGD","LU2272731600.USD","LU0109394709.USD","LU1852331112.SGD","LU2244417387.USD","SG9999011175.SGD","LU2106854487.HKD","LU2125909247.SGD","LU0289739699.SGD","PAWZ","IE00BLSP4452.SGD","LU0477156953.USD","MRVL","HRTS","LU2491050071.SGD","LU1803068979.SGD","LOW","LU2433249047.HKD","SG9999002232.USD","XDAT","LU2506951958.HKD","LU0124676726.USD","LU2360107325.USD","LU2272731865.HKD","LU0456855351.SGD","LU0823421416.USD","LU1066051498.USD","LU1074936037.SGD","LU2237438978.USD","LU2458330169.SGD","IE0009355771.USD","HAKY","LU0098860793.USD","SG9999002224.SGD","LU0070302665.USD","LU1244550494.USD","BK4130","IE00BJT1NW94.SGD","IE00BSNM7G36.USD","LU1983299246.USD","LU1674673428.USD","LU2237443895.HKD","LU0689626769.HKD","LU1778281490.HKD","LU0965509101.SGD","SG9999001440.SGD","SG9999015952.SGD","LU0882574055.USD","FHLC","LU0861579265.USD","LU0395794307.EUR","IE00B19Z9Z06.USD","LU0238689110.USD","LU0823434740.USD","LU0476273544.USD","IE00BBT3K403.USD","MRVU","IE00BMPRXN33.USD","LU1169590202.USD","LU2265009873.SGD","XLV","LU2361044865.SGD","MVLL","BK4566","WDAY","LU2264538146.SGD","SG9999013999.USD","IE00BD6J9T35.USD","IE0004086264.USD","SG9999014005.SGD","IE000BZT7R73.USD","IE00B19Z9P08.USD","LU2404859667.USD","TBXU","LU0289961442.SGD","LU0642271901.SGD","BK4605","LU1934455277.USD","FAI","LU2404859741.USD","LU0077335932.USD","LU2098885051.SGD","LU0868494708.USD","EL","SNOY","SG9999015978.USD","LU1934455194.USD","LU2023251221.USD","LU2089283258.USD","BK4548","PBE","LU0689472784.USD","LU0444971666.USD","SNOW","LU0823434583.USD","LU1003077747.HKD","SG9999015341.SGD","LU2517655291.USD","MRNA","LU1861219969.SGD","BK4592","LU0965509283.SGD","LU1316542783.SGD","LU1935042991.SGD","LU0859254822.USD","IHF","LU0052756011.USD","LU2237443382.USD","IE0034235188.USD","IE0000B7K699.USD","LU2361044949.HKD","LU0130102774.USD","LU0211331839.USD","LU1989772840.SGD","BBH","LU1496350171.SGD","LU2286300806.USD","LU0823417653.USD","LU0889565833.HKD","LU1571399168.USD","LU2360107168.USD","LU1267930573.SGD","LU1992135399.USD","BK4504","WDNA","GLAM","LU1244550577.SGD","IE00BFTCPJ56.SGD","LU0061475181.USD","LU0128525929.USD","BK4598","LU2125909916.SGD","BK4581","LU2211815571.USD","LU1066051225.USD","BK4585","IE00BMPRXQ63.HKD","MRK","BK4516","IE000MB6IJN5.SGD","BK4588","SG9999015945.SGD","LU0094547139.USD","LU1974910355.USD","LU2355687059.USD","BILL","LU0302445910.USD","LU2133065610.SGD","LU0949170772.SGD","LU2517655374.HKD","LU1430594728.SGD","LU0198837287.USD","JDOC","LU1084165304.USD","LU0265550946.USD","SPAM","LU1496350502.SGD","BK4613","LU2125909593.SGD","FXL","LU1712237335.SGD","LU0234570918.USD","LU0310800965.SGD","IBB","LU2041044095.USD","LU0444973449.USD","LU1116320901.HKD","LU0154236417.USD","LU1670711123.USD","LU0965509010.AUD","LU1929549753.HKD","SG9999001176.USD","HCA","IE00BN8TJ469.HKD","LU0128525689.USD","LU0310800379.SGD","LU1923623000.USD","LU2087621335.USD","ADI","LU0726765562.USD","LU2360032135.SGD","IE00BZ199S13.USD","IE00B4R5TH58.HKD","XNTK","BK4007","LU1037948541.HKD","FTXL","LU0320765489.SGD","LU1244550221.USD","LU0820561909.HKD","IE0004445239.USD","LU1951200564.SGD","SG9999003800.SGD","SG9999014567.USD","BK4097","LU0211328371.USD","LU0029864427.USD","LU0320765646.SGD","LU0097036916.USD","IE00B775SV38.USD","LU1303367103.USD","LU2242652126.USD","IXJ","LU0690374961.EUR","BK4560","LU0265550359.USD","LU0957808578.USD","IE000SO60NU8.SGD","WCBR","BK4139","LU0553294199.USD","BK4515","GNOM","LU2129689605.HKD","LU1720051108.HKD","IE00B19Z3581.USD","BK4596","IE00BGHQF631.EUR","BK4116","LU2506951875.HKD","IE00BLSP4239.USD","LU1267930227.SGD","LU0170899867.USD","AIFD","SMHX","04332","SG9999014559.SGD","LU1923622291.USD","SG9999014575.USD","LU1066053197.SGD","LU0203347892.USD","LU2357627491.SGD","LU1093756325.SGD","BK4083","LU1923622614.USD","LU0433182093.SGD","LU1804176565.USD","AIS","LU1978683503.SGD","IE00BMPRXR70.SGD","LU0889565916.HKD","LU2250418816.HKD","CRWD","BK4094","BK4597","IE00B5TLWC47.USD","AGNG","LU1699723380.USD","TGT","LU0069063385.USD","LU1992135472.HKD","LU2506952097.USD","LU1061106388.HKD","LU2468319806.SGD","BK4551","LU1989764664.SGD","PCTY","LU1261432733.SGD","LU2552382132.HKD","LU0724618433.USD","BK4503","BK4141","LU0208291251.USD","LU1035773651.USD","LU1691799644.USD","LU0878866978.SGD","SG9999015358.SGD","LU0823421333.USD","DTCR","LU0985489474.SGD","LU0053666078.USD","PSWD","LU1989764748.USD","LU1670710588.SGD","LU1861215975.USD","LU0648001328.SGD","LU0114720955.EUR","LU2237443465.HKD","LU2275660780.HKD","QQQA","LU0312595415.SGD","LU1551013342.USD","IE00BVYPNW00.USD","LU0234572021.USD","GDOC","BK4512","IBBQ","IE00B42XCP33.USD","LU1150488135.SGD","LU1670627923.USD","LU2237443978.SGD","LU1201861249.SGD","IE00B894F039.SGD","LU0708994859.HKD","LU0203345920.USD","BK4155","BK4607","LU1066051811.HKD","BK4559","LU1674673691.USD","WUGI","LU2324357040.USD","LU2347655073.USD","LU1642822529.SGD","LU0056508442.USD","BK4543","LU0795875086.SGD","LU0823411888.USD","LU0823416689.USD","LU2473716301.USD","RXL","LU1489326972.SGD","BK4023","LU1670628061.USD","LU1951198990.SGD","LU0432979614.USD","IE00B3S45H60.SGD","LU2125154935.USD","LU0187121727.USD","LU2931357623.SGD","BK4554","LU2543165471.USD","LU1718418525.SGD","LU2125154778.USD","LU0109392836.USD","LU2089284900.SGD","LU0274383776.USD","CRWL","LU2089984988.USD","LU0124384867.USD","LU1732799900.SGD","LU0106261372.USD","LU1935043536.SGD","BK4532","LU0082616367.USD","LU2361045086.USD","LU0266013472.USD","LU0057025933.USD","WOLF","LU1069347547.HKD","LU1116320737.USD","LU1988902786.USD","LU2112291526.USD","LU0314106906.USD","LU0006306889.USD","LU1506573853.SGD","LU2272731782.SGD","DAT","LU1548497426.USD","LU1989773731.SGD","LU2322448957.HKD","LU1989772923.USD","LU0210528500.USD","BK4568","IHE","IE00BKVL7J92.USD","LU2491050154.USD","LU1670710661.SGD","LU2360108059.USD","LU1934455863.HKD","LU0472753341.HKD","LU0719512351.SGD","SG9999014013.SGD","AIPI","LU2347655156.SGD","PPH","LU0314104364.USD","LU2290526834.HKD","IE0002141913.USD","FTXH","BK4561","LU0786609619.USD","BK4183","AMGN","SOXY","IE00B19Z3B42.SGD","LU2491049909.HKD","LU2125909759.SGD","LU0942090050.USD","LU1119994496.HKD","BK4604","LU0980610538.SGD","IE00BZ1G4Q59.USD","BK4114","LU0738911758.USD","LU2237443622.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660472972","title":"港股早評:三大指數高開逾1.1%,生物科技股、黃金股大漲","url":"https://stock-news.laohu8.com/highlight/detail?id=2660472972","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660472972?lang=zh_tw&edition=fundamental","pubTime":"2026-08-20 09:37","pubTimestamp":1787189821,"startTime":"0","endTime":"0","summary":"美股止住三连跌,日韩股市大幅反弹。港股三大指数集体高开,恒指涨1.11%,国指涨1.27%,恒生科技指数涨1.69%。大型科网股全线上涨,京东涨近3%,美团、阿里巴巴涨2%,腾讯、小米、百度皆上涨;mRNA肿瘤疫苗三期大获成功,全产业链迎来价值重估,生物医药股大涨,康希诺生物、云顶新耀大涨15%,金斯瑞生物科技大涨13%,金价大涨,黄金股领衔有色金属股上涨,另外,消费电子股、海运股、煤炭股部分走低。(格隆汇)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260820/32340660.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK4588","VXUS","159562","GLDW","BIOY","TBXU","KCAI","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660476170","title":"AI生物科技股Twist Bioscience升逾22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2660476170","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660476170?lang=zh_tw&edition=fundamental","pubTime":"2026-08-20 06:26","pubTimestamp":1787178401,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["AGIX","CHAT","AIPO","VTHR","QTOC","ARTY","BIOY","TBXU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660473644","title":"福泰製藥(VRTX)股票8月19日收盤上漲4.48%:釋放什麼信號?","url":"https://stock-news.laohu8.com/highlight/detail?id=2660473644","media":"TradingKey中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660473644?lang=zh_tw&edition=fundamental","pubTime":"2026-08-20 04:16","pubTimestamp":1787170582,"startTime":"0","endTime":"0","summary":"• 在竞争对手临床试验宣告失败后,福泰制药股价飙升至历史新高。\n• 第二季度营收超出预期,公司同时上调了全年业绩指引。\n• 分析师纷纷给出看涨评级,平均目标价达 563.25 美元。","market":"nz","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/zh-hans/news/market-movers/262119125-market-movers-vrtx-20260819","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TBXU","LU1035775433.USD","LU2324357040.USD","LU2468319806.SGD","VRTX","LU0432979614.USD","BBH","LU1778281490.HKD","IE00B19Z3B42.SGD","LU2237438978.USD","IE00B4R5TH58.HKD","SG9999001176.SGD","IE0002270589.USD","IE00BJT1NW94.SGD","LU0058720904.USD","LU1585245621.USD","IDNA","IE0009355771.USD","IE00B19Z3581.USD","SGXZ57979304.SGD","IE00B19Z9Z06.USD","LU2456880835.USD","LU0417517546.SGD","LU2462157665.USD","IBB","LU1093756325.SGD","GNMX","LU0079474960.USD","LU0256863811.USD","PBE","BIB","LU2362541513.USD","BK4588","LU1674673428.USD","LU0823416689.USD","BK4532","LU2417539215.USD","LU0234570918.USD","BK4139","LU2362541273.HKD","IBBQ","LU0109394709.USD","IE00BFTCPJ56.SGD","LU1069344957.HKD","LU1674673691.USD","BK4567","LU2236285917.USD","LU0289739699.SGD","LU0320765992.SGD","IE00B19Z9P08.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660113478","title":"吉利德科學(GILD)股票8月19日盤中上漲3.66%:背後推手曝光","url":"https://stock-news.laohu8.com/highlight/detail?id=2660113478","media":"TradingKey中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660113478?lang=zh_tw&edition=fundamental","pubTime":"2026-08-20 03:17","pubTimestamp":1787167048,"startTime":"0","endTime":"0","summary":"• 得益于HIV产品组合增长加速,吉利德上调了全年销售指引。\n• 联邦法院颁布禁令阻止海外进口,以保护其核心市场份额。\n• 分析师给予“买入”评级,平均目标价为157.79美元。","market":"us","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/zh-hans/news/market-movers/262118864-market-movers-gild-20260819","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1066051498.USD","LU0965509101.SGD","BBH","BK4583","LU0058720904.USD","LU1057294990.SGD","LU1674673428.USD","LU2468319806.SGD","LU0289739699.SGD","BMED","LU0965508806.USD","LU2324357040.USD","LU0965509283.SGD","LU1934455194.USD","LU1839511570.USD","LU1934455863.HKD","SG9999015986.USD","LU1585245621.USD","BK4139","IE00BKVL7J92.USD","SG9999015952.SGD","LU1934455277.USD","TBXU","BK4532","LU0965509010.AUD","LU1778281490.HKD","TMED","BIB","BK4588","SG9999015978.USD","GILD","LU1023059063.AUD","IBBQ","LU0823416689.USD","LU1674673691.USD","IE00B7SZLL34.SGD","LU0234570918.USD","LU0320765992.SGD","IE00BZ1G4Q59.USD","IBB","IE0002270589.USD","IE00B19Z3581.USD","IE00B19Z3B42.SGD","IE00BSNM7G36.USD","BK4578","BK4550","MEDI","LU1037948541.HKD","SG9999015945.SGD","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660819420","title":"安進(AMGN)股票8月19日盤中上漲3.19%:背後推手曝光","url":"https://stock-news.laohu8.com/highlight/detail?id=2660819420","media":"TradingKey中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660819420?lang=zh_tw&edition=fundamental","pubTime":"2026-08-20 02:16","pubTimestamp":1787163383,"startTime":"0","endTime":"0","summary":"• Argus上调安进目标价,并重申“买入”评级。\n• 第二季度财务业绩超出华尔街的营收和盈利预期。\n• 技术指标显示 MACD 买入信号及 RSI 买入条件。","market":"other","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/zh-hans/news/market-movers/262118749-market-movers-amgn-20260819","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LU0122379950.USD","TBXU","PJP","SG9999001440.SGD","IBB","LU0289739699.SGD","IE00B2B36J28.USD","BK4585","BIB","BK4533","BK4534","LU0320765992.SGD","LU2242646821.SGD","BBH","AMGN","LU0058720904.USD","LU0109394709.USD","IE00BFTCPJ56.SGD","LU1023059063.AUD","PBE","LU1983299246.USD","BK4139","LU2468319806.SGD","LU1061106388.HKD","BK4566","IE00B4R5TH58.HKD","LU2242652126.USD","BK4581","IE0002141913.USD","LU1571399168.USD","IE00BJJMRZ35.SGD","LU2089984988.USD","LU0868494617.USD","IBBQ","LU1057294990.SGD","LU2112291526.USD","BK4599","IE00BJT1NW94.SGD","LU0889565916.HKD","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1105025052","title":"再生元製藥旗下Pasatru獲歐洲藥品管理局審評,全球申報在即","url":"https://stock-news.laohu8.com/highlight/detail?id=1105025052","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1105025052?lang=zh_tw&edition=fundamental","pubTime":"2026-08-20 02:00","pubTimestamp":1787162410,"startTime":"0","endTime":"0","summary":"再生元制药公司宣布,其研发的药物Pasatru已被欧洲药品管理局纳入审评流程。与此同时,该公司正积极筹备在全球范围内提交该药物的上市申请。欧洲药品管理局的审评启动,为这款药物在欧洲地区的获批前景增添了重要砝码。业界分析认为,Pasatru若能顺利通过审评,有望为相关疾病领域带来新的治疗选择。再生元制药在创新药物研发领域深耕多年,此次针对Pasatru的全球布局,也彰显了其对这一候选药物商业潜力的信心。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBB","REGN","LU0058720904.USD","LU1974910355.USD","LU0823434583.USD","LU0882574055.USD","LU0823434740.USD","TBXU","LU0320765992.SGD","LU0289739699.SGD","LU0109394709.USD","LU2237438978.USD","LU0889565916.HKD","BK4139","LU0114720955.EUR","BK4585","LU1917777945.USD","LU2468319806.SGD","LU2362541273.HKD","LU2089984988.USD","LU2362540622.SGD","LU0823416689.USD","LU0053666078.USD","IBBQ","LU2362541513.USD","LU2023250504.SGD","BBH","LU2106854487.HKD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1188134905","title":"再生元製藥獲FDA批准:Pasatru(Garetosmab-Grts)上市,治療成人進行性骨化性纖維發育不良","url":"https://stock-news.laohu8.com/highlight/detail?id=1188134905","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1188134905?lang=zh_tw&edition=fundamental","pubTime":"2026-08-20 01:59","pubTimestamp":1787162353,"startTime":"0","endTime":"0","summary":"再生元制药公司今日宣布,其研发的新药Pasatru已获得美国食品药品监督管理局的正式批准,用于治疗成人进行性骨化性纤维发育不良。这一罕见疾病此前一直缺乏有效的治疗手段,此次获批为患者带来了新的希望。FDA的此次批准基于多项临床研究数据,结果显示Pasatru在减缓异位骨化进展方面表现出显著疗效,且安全性可控。未来,再生元制药计划进一步拓展Pasatru的适应症范围,并探索其在其他相关疾病中的潜在应用。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0289739699.SGD","IBBQ","LU0114720955.EUR","LU1974910355.USD","LU2106854487.HKD","LU2362540622.SGD","LU0882574055.USD","BBH","LU2468319806.SGD","BK4139","LU2237438978.USD","REGN","LU0053666078.USD","LU0823434740.USD","LU2089984988.USD","LU0823416689.USD","LU0320765992.SGD","IBB","LU0889565916.HKD","LU2023250504.SGD","LU0109394709.USD","LU2362541273.HKD","TBXU","LU0823434583.USD","LU2362541513.USD","BK4585","LU1917777945.USD","LU0058720904.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660447273","title":"受利好消息提振,美股生物科技股普漲","url":"https://stock-news.laohu8.com/highlight/detail?id=2660447273","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660447273?lang=zh_tw&edition=fundamental","pubTime":"2026-08-19 19:21","pubTimestamp":1787138473,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BIOY","TBXU"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":8,"pageCount":3,"totalSize":151,"code":"91000000","status":"200"}]}}